Thurston Springer Miller Herd & Titak’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.33K Hold
63
﹤0.01% 977
2026
Q1
$4.45K Sell
63
-133
-68% -$9.96K ﹤0.01% 1065
2025
Q4
$15.5K Buy
+196
New +$15.5K 0.01% 822
2025
Q3
Sell
-1,198
Closed -$96.3K 1042
2025
Q2
$96.3K Buy
1,198
+429
+56% +$33.1K 0.01% 513
2025
Q1
$61.7K Buy
769
+48
+7% +$3.99K 0.01% 568
2024
Q4
$59K Sell
721
-36
-5% -$3K 0.01% 499
2024
Q3
$62.4K Buy
757
+467
+161% +$34.9K 0.02% 505
2024
Q2
$20.4K Buy
+290
New +$20.7K 0.01% 804

Other funds holding MET

Thurston Springer Miller Herd & Titak's MET Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its MetLife (MET) position steady in Q2 2026 at 63 shares worth $5.33K. The position accounts for ﹤0.01% of the portfolio, ranked #977.

Thurston Springer Miller Herd & Titak first reported a position in MET in Q2 2024 and has held it in 8 quarters since. The position peaked at $96.3K in Q2 2025. 1,446 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 63 shares of MetLife worth $5.33K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its MetLife share count unchanged in Q2 2026.
  • MetLife made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #977 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in MetLife in Q2 2024 and has held it in 8 quarters since.
  • Thurston Springer Miller Herd & Titak's MetLife position peaked at $96.3K in Q2 2025.
  • 1,446 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.